[SCHEDULE 13G/A] Greenlane Holdings, Inc. SEC Filing
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP and Altium Healthcare Long Short GP LLC jointly report beneficial ownership related to Greenlane Holdings, Inc. common stock (CUSIP 395330509). The filing shows 21,008 shares of common stock that would be issuable upon full conversion/exercise of Series A Warrants, representing 0.12% of the class based on 17,394,226 shares outstanding as reported by the issuer. The reported counts do not give effect to a 4.99% Warrant Blocker, which prevents the Reporting Persons from exercising warrants if doing so would increase their ownership above 4.99%, so the actual post-blocker ownership is lower than reported.
The filing discloses that the Fund is the direct record owner and that Altium Capital Management LLC and Altium Healthcare Long Short GP LLC may be deemed to beneficially own the securities due to advisory and general partner roles. The parties certify the securities were not acquired to change or influence control of the issuer.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP e Altium Healthcare Long Short GP LLC dichiarano congiuntamente la titolarit脿 effettiva relativa alle azioni ordinarie di Greenlane Holdings, Inc. (CUSIP 395330509). Il deposito indica 21,008 azioni di capitale che sarebbero emesse in caso di completa conversione/esercizio dei Warrant di Serie A, pari al 0.12% della classe sulla base di 17,394,226 azioni in circolazione come riportato dall'emittente. I conteggi segnalati non tengono conto di un Warrant Blocker del 4.99%, che impedisce alle persone segnalanti di esercitare i warrant se ci貌 aumenterebbe la loro partecipazione oltre il 4.99%, pertanto la reale partecipazione post-blocco 猫 inferiore a quella riportata.
Il deposito dichiara che il Fondo 猫 il proprietario diretto nei registri e che Altium Capital Management LLC e Altium Healthcare Long Short GP LLC possono essere considerati titolari effettivi dei titoli in ragione dei loro ruoli di advisor e general partner. Le parti certificano che i titoli non sono stati acquisiti per modificare o influenzare il controllo dell'emittente.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP y Altium Healthcare Long Short GP LLC informan conjuntamente la propiedad beneficiaria relacionada con las acciones ordinarias de Greenlane Holdings, Inc. (CUSIP 395330509). La presentaci贸n muestra 21,008 acciones ordinarias que se emitir铆an tras la conversi贸n/ejercicio completo de los Warrants Serie A, lo que representa el 0.12% de la clase sobre una base de 17,394,226 acciones en circulaci贸n seg煤n lo informado por el emisor. Los recuentos notificados no consideran un bloqueo de warrants del 4.99%, que impide a las personas informantes ejercer los warrants si con ello su participaci贸n superar铆a el 4.99%, por lo que la tenencia real tras el bloqueo es inferior a la informada.
La presentaci贸n revela que el Fondo es el propietario registrado directo y que Altium Capital Management LLC y Altium Healthcare Long Short GP LLC pueden considerarse beneficiarios de los valores debido a sus funciones de asesor y socio general. Las partes certifican que los valores no fueron adquiridos para cambiar o influir en el control del emisor.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP 氚� Altium Healthcare Long Short GP LLC電� 瓿惦彊鞙茧 Greenlane Holdings, Inc. 氤错喌欤�(CUSIP 395330509)鞐� 雽�頃� 鞁れ鞝� 靻岇湢毳� 氤搓碃頃╇媹雼�. 鞝滌稖靹滊電� Series A 鞗岆煱韸胳潣 鞝勴櫂/頄夓偓臧� 鞕勲霅� 瓴届毎 氚滍枆霅� 21,008欤�鞚� 氤错喌欤茧ゼ 雮橅儉雮措┌, 鞚措姅 氚滍枆靷皜 氤搓碃頃� 17,394,226欤检潣 氚滍枆欤检嫕靾橂ゼ 旮办鞙茧 韥措灅鞀れ潣 0.12%鞐� 頃措嫻頃╇媹雼�. 氤搓碃霅� 靾橃箻電� 氤挫湢 牍勳鞚� 4.99%毳� 齑堦臣頃橃 鞎婋弰搿� 鞗岆煱韸� 頄夓偓毳� 鞝滍暅頃橂姅 4.99% 鞗岆煱韸� 敫旊旎�毳� 氚橃榿頃橃 鞎婌溂氙�搿�, 敫旊旎� 鞝侅毄 頉� 鞁れ牅 氤挫湢 牍勳鞚� 氤搓碃霅� 靾橃箻氤措嫟 雮姷雼堧嫟.
靹滊電� 韼�霌滉皜 霌标赴靸� 歆侅爲 靻岇湢鞛愳澊氅� Altium Capital Management LLC鞕� Altium Healthcare Long Short GP LLC電� 鞛愲 氚� 齑濌磩 韺岉姼雱� 鞐暊搿� 鞚疙暣 頃措嫻 歃濌秾鞚� 鞁れ鞝� 靻岇湢鞛愲 臧勳＜霅� 靾� 鞛堨潓鞚� 氚濏灆雼堧嫟. 雼轨偓鞛愲摛鞚� 頃措嫻 歃濌秾鞚� 氚滍枆靷潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 欤缄赴 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 頇曥澑頃╇媹雼�.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP et Altium Healthcare Long Short GP LLC d茅clarent conjointement la propri茅t茅 b茅n茅ficiaire des actions ordinaires de Greenlane Holdings, Inc. (CUSIP 395330509). Le d茅p么t indique 21,008 actions ordinaires qui seraient 茅mises en cas de conversion/exercice int茅gral des warrants de s茅rie A, repr茅sentant 0.12% de la cat茅gorie sur la base de 17,394,226 actions en circulation telles que rapport茅es par l'茅metteur. Les chiffres rapport茅s ne tiennent pas compte d'un m茅canisme de blocage des warrants 脿 4,99%, qui emp锚che les d茅clarants d'exercer des warrants si cela portait leur participation au鈥慸essus de 4,99%, de sorte que la participation r茅elle apr猫s application du blocage est inf茅rieure 脿 celle d茅clar茅e.
Le d茅p么t pr茅cise que le Fonds est le propri茅taire inscrit direct et que Altium Capital Management LLC et Altium Healthcare Long Short GP LLC peuvent 锚tre r茅put茅s d茅tenir b茅n茅ficiairement les titres en raison de leurs r么les de conseiller et de partenaire g茅n茅ral. Les parties certifient que les titres n'ont pas 茅t茅 acquis dans le but de changer ou d'influencer le contr么le de l'茅metteur.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP und Altium Healthcare Long Short GP LLC melden gemeinsam die wirtschaftliche Eigent眉merschaft an den Stammaktien von Greenlane Holdings, Inc. (CUSIP 395330509). Die Meldung weist 21,008 Aktien aus, die bei vollst盲ndiger Umwandlung/Einl枚sung der Series A Warrants ausgebbar w盲ren, was 0.12% der Klasse entspricht, basierend auf 17,394,226 ausstehenden Aktien, wie vom Emittenten angegeben. Die angegebenen Zahlen ber眉cksichtigen keinen 4.99% Warrant-Blocker, der den Meldern das Aus眉ben der Warrants untersagt, falls dadurch ihre Beteiligung 眉ber 4.99% steigen w眉rde; die tats盲chliche Beteiligung nach Anwendung des Blockers ist daher geringer als gemeldet.
Die Einreichung gibt an, dass der Fonds der direkte eingetragene Eigent眉mer ist und dass Altium Capital Management LLC sowie Altium Healthcare Long Short GP LLC aufgrund ihrer Rollen als Berater bzw. General Partner als wirtschaftliche Eigent眉mer der Wertpapiere angesehen werden k枚nnen. Die Parteien best盲tigen, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen.
- Disclosure of 21,008 shares issuable on conversion of Series A Warrants provides transparent quantification of potential dilution and interest
- Clear disclosure of a 4.99% Warrant Blocker that limits exercise and clarifies the maximum potential ownership outcome
- Joint filing by Altium entities clarifies advisory and GP relationships and the source of deemed beneficial ownership
- None.
Insights
TL;DR: Small, non-controlling position disclosed; warrants noted but limited by a 4.99% blocker.
The Schedule 13G/A records 21,008 shares attributable to Altium entities via Series A Warrants, equal to 0.12% of the outstanding common stock on the issuer's reported share base. The filing explicitly states a 4.99% Warrant Blocker, and the reported numbers do not reflect the blocker, meaning actual exercisable ownership will be lower. Item 10 includes a certification that the position was not acquired to influence control, consistent with a passive 13G reporting posture. Materiality to shareholders appears limited given the small percentage of the class.
TL;DR: Disclosure is clear on ownership mechanics and limits; negligible governance impact at reported levels.
The filing names the Fund as the direct record owner and identifies Altium Capital Management LLC and the GP as advisor and general partner respectively, clarifying relationships that can create deemed beneficial ownership. The inclusion of the Warrant Blocker and the explicit statement that the securities were not acquired to change control reduce potential governance concerns. With only 0.12% reported, there is no indication of a control threat or group formation affecting board composition from this disclosure alone.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP e Altium Healthcare Long Short GP LLC dichiarano congiuntamente la titolarit脿 effettiva relativa alle azioni ordinarie di Greenlane Holdings, Inc. (CUSIP 395330509). Il deposito indica 21,008 azioni di capitale che sarebbero emesse in caso di completa conversione/esercizio dei Warrant di Serie A, pari al 0.12% della classe sulla base di 17,394,226 azioni in circolazione come riportato dall'emittente. I conteggi segnalati non tengono conto di un Warrant Blocker del 4.99%, che impedisce alle persone segnalanti di esercitare i warrant se ci貌 aumenterebbe la loro partecipazione oltre il 4.99%, pertanto la reale partecipazione post-blocco 猫 inferiore a quella riportata.
Il deposito dichiara che il Fondo 猫 il proprietario diretto nei registri e che Altium Capital Management LLC e Altium Healthcare Long Short GP LLC possono essere considerati titolari effettivi dei titoli in ragione dei loro ruoli di advisor e general partner. Le parti certificano che i titoli non sono stati acquisiti per modificare o influenzare il controllo dell'emittente.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP y Altium Healthcare Long Short GP LLC informan conjuntamente la propiedad beneficiaria relacionada con las acciones ordinarias de Greenlane Holdings, Inc. (CUSIP 395330509). La presentaci贸n muestra 21,008 acciones ordinarias que se emitir铆an tras la conversi贸n/ejercicio completo de los Warrants Serie A, lo que representa el 0.12% de la clase sobre una base de 17,394,226 acciones en circulaci贸n seg煤n lo informado por el emisor. Los recuentos notificados no consideran un bloqueo de warrants del 4.99%, que impide a las personas informantes ejercer los warrants si con ello su participaci贸n superar铆a el 4.99%, por lo que la tenencia real tras el bloqueo es inferior a la informada.
La presentaci贸n revela que el Fondo es el propietario registrado directo y que Altium Capital Management LLC y Altium Healthcare Long Short GP LLC pueden considerarse beneficiarios de los valores debido a sus funciones de asesor y socio general. Las partes certifican que los valores no fueron adquiridos para cambiar o influir en el control del emisor.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP 氚� Altium Healthcare Long Short GP LLC電� 瓿惦彊鞙茧 Greenlane Holdings, Inc. 氤错喌欤�(CUSIP 395330509)鞐� 雽�頃� 鞁れ鞝� 靻岇湢毳� 氤搓碃頃╇媹雼�. 鞝滌稖靹滊電� Series A 鞗岆煱韸胳潣 鞝勴櫂/頄夓偓臧� 鞕勲霅� 瓴届毎 氚滍枆霅� 21,008欤�鞚� 氤错喌欤茧ゼ 雮橅儉雮措┌, 鞚措姅 氚滍枆靷皜 氤搓碃頃� 17,394,226欤检潣 氚滍枆欤检嫕靾橂ゼ 旮办鞙茧 韥措灅鞀れ潣 0.12%鞐� 頃措嫻頃╇媹雼�. 氤搓碃霅� 靾橃箻電� 氤挫湢 牍勳鞚� 4.99%毳� 齑堦臣頃橃 鞎婋弰搿� 鞗岆煱韸� 頄夓偓毳� 鞝滍暅頃橂姅 4.99% 鞗岆煱韸� 敫旊旎�毳� 氚橃榿頃橃 鞎婌溂氙�搿�, 敫旊旎� 鞝侅毄 頉� 鞁れ牅 氤挫湢 牍勳鞚� 氤搓碃霅� 靾橃箻氤措嫟 雮姷雼堧嫟.
靹滊電� 韼�霌滉皜 霌标赴靸� 歆侅爲 靻岇湢鞛愳澊氅� Altium Capital Management LLC鞕� Altium Healthcare Long Short GP LLC電� 鞛愲 氚� 齑濌磩 韺岉姼雱� 鞐暊搿� 鞚疙暣 頃措嫻 歃濌秾鞚� 鞁れ鞝� 靻岇湢鞛愲 臧勳＜霅� 靾� 鞛堨潓鞚� 氚濏灆雼堧嫟. 雼轨偓鞛愲摛鞚� 頃措嫻 歃濌秾鞚� 氚滍枆靷潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 欤缄赴 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 頇曥澑頃╇媹雼�.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP et Altium Healthcare Long Short GP LLC d茅clarent conjointement la propri茅t茅 b茅n茅ficiaire des actions ordinaires de Greenlane Holdings, Inc. (CUSIP 395330509). Le d茅p么t indique 21,008 actions ordinaires qui seraient 茅mises en cas de conversion/exercice int茅gral des warrants de s茅rie A, repr茅sentant 0.12% de la cat茅gorie sur la base de 17,394,226 actions en circulation telles que rapport茅es par l'茅metteur. Les chiffres rapport茅s ne tiennent pas compte d'un m茅canisme de blocage des warrants 脿 4,99%, qui emp锚che les d茅clarants d'exercer des warrants si cela portait leur participation au鈥慸essus de 4,99%, de sorte que la participation r茅elle apr猫s application du blocage est inf茅rieure 脿 celle d茅clar茅e.
Le d茅p么t pr茅cise que le Fonds est le propri茅taire inscrit direct et que Altium Capital Management LLC et Altium Healthcare Long Short GP LLC peuvent 锚tre r茅put茅s d茅tenir b茅n茅ficiairement les titres en raison de leurs r么les de conseiller et de partenaire g茅n茅ral. Les parties certifient que les titres n'ont pas 茅t茅 acquis dans le but de changer ou d'influencer le contr么le de l'茅metteur.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP und Altium Healthcare Long Short GP LLC melden gemeinsam die wirtschaftliche Eigent眉merschaft an den Stammaktien von Greenlane Holdings, Inc. (CUSIP 395330509). Die Meldung weist 21,008 Aktien aus, die bei vollst盲ndiger Umwandlung/Einl枚sung der Series A Warrants ausgebbar w盲ren, was 0.12% der Klasse entspricht, basierend auf 17,394,226 ausstehenden Aktien, wie vom Emittenten angegeben. Die angegebenen Zahlen ber眉cksichtigen keinen 4.99% Warrant-Blocker, der den Meldern das Aus眉ben der Warrants untersagt, falls dadurch ihre Beteiligung 眉ber 4.99% steigen w眉rde; die tats盲chliche Beteiligung nach Anwendung des Blockers ist daher geringer als gemeldet.
Die Einreichung gibt an, dass der Fonds der direkte eingetragene Eigent眉mer ist und dass Altium Capital Management LLC sowie Altium Healthcare Long Short GP LLC aufgrund ihrer Rollen als Berater bzw. General Partner als wirtschaftliche Eigent眉mer der Wertpapiere angesehen werden k枚nnen. Die Parteien best盲tigen, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen.
FAQ
How many Greenlane Holdings (GNLN) shares do the Altium filers report?
What percentage of GNLN does the reported position represent?
Are these shares currently exercisable or otherwise limited?
Who filed the Schedule 13G/A for GNLN?
Does the filing indicate intent to influence control of Greenlane?
